Cenobamate
Brand name: Xcopri
Rank #261 of 500 drugs by total cost
$47.6M
Total Cost
33,831
Total Claims
$47.6M
Total Cost
779
Prescribers
$1,406
Cost per Claim
2,242
Beneficiaries
36,653
30-Day Fills
$61K
Avg Cost/Provider
43
Avg Claims/Provider
About Cenobamate
Cenobamate (sold as Xcopri) was prescribed 33,831 times by 779 Medicare Part D providers in 2023, costing the program $47.6M. At $1,406 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 258 | Sucralfate (Sucralfate) | $48.5M | 689,007 |
| 259 | Diroximel Fumarate (Vumerity) | $48.5M | 5,351 |
| 260 | Cabotegravir/Rilpivirine (Cabenuva) | $48.1M | 7,384 |
| 261 | Cenobamate (Xcopri) | $47.6M | 33,831 |
| 262 | Clozapine (Clozapine) | $47.0M | 491,951 |
| 263 | Pembrolizumab (Keytruda) | $46.9M | 3,947 |
| 264 | Glipizide (Glipizide) | $46.9M | 2,961,035 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology